These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6737430)

  • 1. Tumor inhibitory triazenes. 3. Dealkylation within an homologous series and its relation to antitumor activity.
    Wilman DE; Cox PJ; Goddard PM; Hart LI; Merai K; Newell DR
    J Med Chem; 1984 Jul; 27(7):870-4. PubMed ID: 6737430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor inhibitory triazenes. 2. Variation of antitumor activity within an homologous series.
    Wilman DE; Goddard PM
    J Med Chem; 1980 Sep; 23(9):1052-4. PubMed ID: 7411549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of the mode of action of antitumor triazenes and triazines. 6. 1-Aryl-3-(hydroxymethyl)-3-methyltriazenes: synthesis, chemistry, and antitumor properties.
    Vaughan K; Tang Y; Llanos G; Horton JK; Simmonds RJ; Hickman JA; Stevens MF
    J Med Chem; 1984 Mar; 27(3):357-63. PubMed ID: 6699881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour inhibitory triazenes: structural requirements for an active metabolite.
    Connors TA; Goddard PM; Merai K; Ross WC; Wilman DE
    Biochem Pharmacol; 1976 Feb; 25(3):241-6. PubMed ID: 1267820
    [No Abstract]   [Full Text] [Related]  

  • 5. Preparation and antitumor activity of 1-aryl-3,3-dimethyltriazene derivatives.
    Giraldi T; Nisi C; Connors TA; Goddard PM
    J Med Chem; 1977 Jun; 20(6):850-3. PubMed ID: 874961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of cluster analysis in the development of structure-activity relations for antitumor triazenes.
    Dunn WJ; Greenberg MJ; Callejas SS
    J Med Chem; 1976 Nov; 19(11):1299-301. PubMed ID: 1003406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the mechanism of action of the tumour inhibitory triazenes.
    Audette RC; Connors TA; Mandel HG; Merai K; Ross WC
    Biochem Pharmacol; 1973 Aug; 22(15):1855-64. PubMed ID: 4722457
    [No Abstract]   [Full Text] [Related]  

  • 8. Antitumor 1-(X-aryl)-3,3-dialkyltriazenes. 1. Quantitative structure-activity relationships vs. L1210 leukemia in mice.
    Hatheway GJ; Hansch C; Kim KH; Milstein SR; Schmidt CL; Smith RN; Quinn FR
    J Med Chem; 1978 Jun; 21(6):563-74. PubMed ID: 671453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, physicochemical properties, and antitumor activities of analogs of 1-phenyl-3-benzyl-3-methyltriazenes.
    Dunn WJ; Greenberg MJ
    J Pharm Sci; 1977 Oct; 66(10):1416-9. PubMed ID: 21950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and antitumor activity of derivatives of 1-phenyl-3,3-dimethyltriazene.
    Lin YT; Loo TL
    J Med Chem; 1972 Feb; 15(2):201-3. PubMed ID: 5008242
    [No Abstract]   [Full Text] [Related]  

  • 11. The utility of information content, structural information content, hydrophobicity and van der Waals volume in the design of barbiturates and tumor inhibitory triazenes. A comparative study.
    Ray SK; Basak SC; Raychaudhury C; Roy AB; Ghosh JJ
    Arzneimittelforschung; 1983; 33(3):352-6. PubMed ID: 6683508
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis and antitumor activity of alkyltriazenopyrazoles.
    Zakharieva RD; Spassova MK; Karaivanova MC; Golovinsky EV
    Arzneimittelforschung; 1984; 34(6):661-3. PubMed ID: 6541485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triazene drug metabolites. Part 17: Synthesis and plasma hydrolysis of acyloxymethyl carbamate derivatives of antitumour triazenes.
    Carvalho E; Francisco AP; Iley J; Rosa E
    Bioorg Med Chem; 2000 Jul; 8(7):1719-25. PubMed ID: 10976519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antitumor activity of halogen-substituted 4-(3,3-dimethyl-1-triazeno)quinolines.
    Lin AJ; Loo TL
    J Med Chem; 1978 Mar; 21(3):268-72. PubMed ID: 628002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antitumor activity of hydrosoluble analogs of p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt.
    Varnavas A; Nisi C; Lassiani L; Sava G; Perissin L; Boccù E
    Arzneimittelforschung; 1991 Nov; 41(11):1168-72. PubMed ID: 1810263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional-group modifications of dextran for linkage to a diazonium group. A potential vehicle for tumour targeting of antineoplastic triazenes.
    Baki AV; Vaughan K
    Carbohydr Res; 1982 Jul; 105(1):57-68. PubMed ID: 6180830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microsomal mediated metabolism of dialkylaryltriazenes. I. Demethylation of ring halogenated 3,3-dimethyl-1-phenyltriazenes.
    Pool BL
    J Cancer Res Clin Oncol; 1979 Apr; 93(3):215-20. PubMed ID: 468884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Synthesis and antitumour activity of 8-triazenopurines].
    Zhang WN
    Yao Xue Xue Bao; 1982 Dec; 17(12):909-16. PubMed ID: 7183123
    [No Abstract]   [Full Text] [Related]  

  • 19. 1,3-Dialkyl-3-acyltriazenes, a novel class of antineoplastic alkylating agents.
    Smith RH; Scudiero DA; Michejda CJ
    J Med Chem; 1990 Sep; 33(9):2579-83. PubMed ID: 2391696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of the mode of action of antitumour triazenes and triazines-II. Investigation of the selective toxicity of 1-aryl-3,3-dimethyltriazenes.
    Gescher A; Hickman JA; Simmonds RJ; Stevens MF; Vaughan K
    Biochem Pharmacol; 1981 Jan; 30(1):89-93. PubMed ID: 7213416
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.